Investor Overview

Corporate Profile

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Its primary focus is on developing first-in-class oral peptide drugs that specifically target biological pathways also targeted by currently marketed injectable antibody drugs... Read more

Stock Quote

PTGX (Common Stock)
$13.24 + 0.02 (0.15%)
Exchange :NASDAQ
Volume :39,963
Today's Open$12.52
Previous Close$13.22
Data as of March 27, 2017 11:59 a.m. ET
Refresh quote

Stock Chart

Stock chart for: PTGX.O.  Currently trading at $13.24 with a 52 week high of $26.36 and a 52 week low of $10.02.

Recent Press Releases

March 09, 2017

Protagonist Therapeutics to Present at the Oppenheimer & Co. Healthcare Conference read more

March 07, 2017

Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results read more

March 02, 2017

Protagonist Therapeutics to Present at the Barclays Global Healthcare Conference read more

Upcoming Events

There are currently no events scheduled.


Investor Presentation

Data provided by Nasdaq. Minimum 15 minutes delayed.